Kulp SK - Search Results

1

Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.

McMahon MB, Bear MD, Kulp SK, Pennell ML, London CA. McMahon MB, et al. Among authors: kulp sk. Am J Vet Res. 2010 Jul;71(7):799-808. doi: 10.2460/ajvr.71.7.799. Am J Vet Res. 2010. PMID: 20594083 Free article.

2

Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer.

Kulp SK, Chen CS, Wang DS, Chen CY, Chen CS. Kulp SK, et al. Clin Cancer Res. 2006 Sep 1;12(17):5199-206. doi: 10.1158/1078-0432.CCR-06-0429. Clin Cancer Res. 2006. Retraction in: Clin Cancer Res. 2019 May 1;25(9):2940. doi: 10.1158/1078-0432.CCR-19-0731 PMID: 16951239 Retracted.

3

Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines.

Kisseberth WC, Murahari S, London CA, Kulp SK, Chen CS. Kisseberth WC, et al. Among authors: kulp sk. Am J Vet Res. 2008 Jul;69(7):938-45. doi: 10.2460/ajvr.69.7.938. Am J Vet Res. 2008. PMID: 18593248 Free article.

4

3-Phosphoinositide-dependent protein kinase-1/Akt signalling and inhibition in a canine prostate carcinoma cell line.

Alvarez FJ, Murahari S, Couto CG, Rosol TJ, Kulp SK, Chen CS, Kisseberth WC. Alvarez FJ, et al. Among authors: kulp sk. Vet Comp Oncol. 2007 Mar;5(1):47-58. doi: 10.1111/j.1476-5829.2006.00117.x. Vet Comp Oncol. 2007. PMID: 19754801

5

AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit.

Lin TY, Fenger J, Murahari S, Bear MD, Kulp SK, Wang D, Chen CS, Kisseberth WC, London CA. Lin TY, et al. Among authors: kulp sk. Blood. 2010 May 27;115(21):4217-25. doi: 10.1182/blood-2009-07-231985. Epub 2010 Mar 16. Blood. 2010. PMID: 20233974 Free PMC article.

6

Met interacts with EGFR and Ron in canine osteosarcoma.

McCleese JK, Bear MD, Kulp SK, Mazcko C, Khanna C, London CA. McCleese JK, et al. Among authors: kulp sk. Vet Comp Oncol. 2013 Jun;11(2):124-39. doi: 10.1111/j.1476-5829.2011.00309.x. Epub 2011 Dec 8. Vet Comp Oncol. 2013. PMID: 22235915 Free PMC article.

7

Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines.

Couto JI, Bear MD, Lin J, Pennel M, Kulp SK, Kisseberth WC, London CA. Couto JI, et al. Among authors: kulp sk. BMC Vet Res. 2012 Dec 17;8:244. doi: 10.1186/1746-6148-8-244. BMC Vet Res. 2012. PMID: 23244668 Free PMC article.

8

Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells.

Lai IL, Chou CC, Lai PT, Fang CS, Shirley LA, Yan R, Mo X, Bloomston M, Kulp SK, Bekaii-Saab T, Chen CS. Lai IL, et al. Among authors: kulp sk. Carcinogenesis. 2014 Oct;35(10):2203-13. doi: 10.1093/carcin/bgu124. Epub 2014 May 30. Carcinogenesis. 2014. Retraction in: Carcinogenesis. 2019 Apr 29;40(2):e16. doi: 10.1093/carcin/bgz056 PMID: 24879635 Free PMC article. Retracted.

9

Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.

Murahari S, Jalkanen AL, Kulp SK, Chen CS, Modiano JF, London CA, Kisseberth WC. Murahari S, et al. Among authors: kulp sk. BMC Cancer. 2017 Jan 21;17(1):67. doi: 10.1186/s12885-017-3046-6. BMC Cancer. 2017. PMID: 28109246 Free PMC article.

10

Differential effect of keratinocyte growth factor (KGF) on aromatase activity in cultured canine prostatic epithelial cells.

Canatan H, Shidaifat F, Kulp SK, Zhang Y, Chang WY, Brueggemeir RW, Lin YC. Canatan H, et al. Among authors: kulp sk. Endocr Res. 1997 Nov;23(4):311-23. doi: 10.1080/07435809709031860. Endocr Res. 1997. PMID: 9430821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters